Medigen Biotechnology (3176) — Strategic Asset Allocation Index
Medigen Biotechnology (3176) has a Strategic Asset Allocation Index of 37.1% as of June 2023. Strategic assets (PP&E of NT$2.15 Billion plus long-term investments of NT$-) total NT$2.15 Billion, measured against net assets of NT$5.80 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Medigen Biotechnology Strategic Asset Allocation Index (2003–2021)
This chart shows how Medigen Biotechnology's Strategic Asset Allocation Index has evolved across 19 annual periods from 2003 to 2021. As of June 2023, the index stands at 37.1%, representing strategic assets of NT$2.15 Billion against net assets of NT$5.80 Billion TWD. Explore Medigen Biotechnology (3176) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Medigen Biotechnology (2003–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Medigen Biotechnology from 2003 to 2021, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Medigen Biotechnology.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 34.1% | NT$2.19 Billion | NT$2.19 Billion | NT$- | NT$6.43 Billion | ▼ -14.1 pp |
| 2020 | 48.1% | NT$2.17 Billion | NT$2.17 Billion | NT$- | NT$4.50 Billion | ▼ -46.5 pp |
| 2019 | 94.6% | NT$2.54 Billion | NT$2.54 Billion | NT$- | NT$2.69 Billion | ▲ +17.7 pp |
| 2018 | 76.9% | NT$2.26 Billion | NT$2.23 Billion | NT$26.93 Million | NT$2.94 Billion | ▲ +2.3 pp |
| 2017 | 74.6% | NT$2.37 Billion | NT$2.35 Billion | NT$19.56 Million | NT$3.18 Billion | ▲ +6.7 pp |
| 2016 | 67.9% | NT$2.40 Billion | NT$2.38 Billion | NT$28.05 Million | NT$3.54 Billion | ▲ +10.5 pp |
| 2015 | 57.4% | NT$1.99 Billion | NT$1.91 Billion | NT$76.67 Million | NT$3.46 Billion | ▲ +16.8 pp |
| 2014 | 40.6% | NT$1.49 Billion | NT$1.49 Billion | NT$- | NT$3.66 Billion | ▲ +22.1 pp |
| 2013 | 18.6% | NT$570.28 Million | NT$570.28 Million | NT$- | NT$3.07 Billion | ▲ +9.8 pp |
| 2012 | 8.8% | NT$179.79 Million | NT$179.79 Million | NT$- | NT$2.05 Billion | ▼ -0.8 pp |
| 2011 | 9.6% | NT$87.73 Million | NT$87.73 Million | NT$- | NT$915.79 Million | ▼ -0.1 pp |
| 2010 | 9.7% | NT$78.30 Million | NT$78.30 Million | NT$- | NT$807.90 Million | ▼ -1.2 pp |
| 2009 | 10.9% | NT$65.00 Million | NT$65.00 Million | NT$- | NT$597.02 Million | ▲ +1.5 pp |
| 2008 | 9.4% | NT$50.87 Million | NT$50.87 Million | NT$- | NT$539.65 Million | ▲ +6.7 pp |
| 2007 | 2.7% | NT$12.85 Million | NT$12.85 Million | NT$- | NT$468.68 Million | ▲ +1.1 pp |
| 2006 | 1.6% | NT$10.71 Million | NT$10.71 Million | NT$- | NT$667.93 Million | ▲ +0.7 pp |
| 2005 | 0.9% | NT$5.60 Million | NT$5.60 Million | NT$- | NT$650.39 Million | ▼ -0.2 pp |
| 2004 | 1.1% | NT$7.92 Million | NT$7.92 Million | NT$- | NT$739.26 Million | ▼ -0.6 pp |
| 2003 | 1.6% | NT$13.92 Million | NT$13.92 Million | NT$- | NT$856.65 Million | — |